Impact of the national biotechnology strategy on the South African biopharma industry

Abstract

The national biotechnology strategy was published in 2001. The process followed for drafting the strategy is as follows: involvement of experts; wider consultation with stakeholders and adoption and publication. The mandate for the BRICs was to focus on: commercialising biotechnology innovations coming out of universities, research councils, private sector; to focus on three focus areas of human health, bioprocessing, focus on animal health; plant biotechnology for PlantBio; to establish a national bioinformatics capacity to serve the biotechnology innovation needs (NBN) and to Build research-industry linkages